Importer of Controlled Substances; Notice of Application, 65658 [2010-27023]
Download as PDF
<![CDATA[
65658
Federal Register / Vol. 75, No. 206 / Tuesday, October 26, 2010 / Notices
transfer its holdings to a successor
organization or is itself designated the
permanent custodian of the intellectual
property.
Below is the name and contact
information of an individual from
whom additional information
concerning the organization can be
obtained: Carey R. Ramos, Esq.; Paul,
Weiss, Rifkind, Wharton & Garrison
LLP; 1285 Avenue of the Americas; New
York, NY 10019–6064.
Dated: October 19, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator,Office of
Diversion Control,Drug Enforcement
Administration.
Patricia A. Brink,
Deputy Director of Operations, Antitrust
Division.
Importer of Controlled Substances;
Notice of Application
[FR Doc. 2010–26734 Filed 10–25–10; 8:45 am]
BILLING CODE 4410–11–M
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled
Substances;Notice of Application
This is notice that on July 22, 2010,
Cody Laboratories Inc., 601 Yellowstone
Avenue, Cody, Wyoming 82414–9321,
made application by renewal to the
Drug Enforcement Administration
(DEA) for registration as an importer of
the basic classes of controlled
substances listed in schedule II:
Drug
Schedule
emcdonald on DSK2BSOYB1PROD with NOTICES
Raw Opium (9600) .......................
Concentrate of Poppy Straw
(9670).
II
II
The company plans to import narcotic
raw materials for manufacturing and
further distribution to its customers.
The company is registered with DEA as
a manufacturer of several controlled
substances that are manufactured from
raw opium, poppy straw, and
concentrate of poppy straw.
As explained in the Correction to
Notice of Application pertaining to
Rhodes Technologies, 72 FR 3417
(2007), comments and requests for
hearings on applications to import
narcotic raw material are not
appropriate.
As noted in a previous notice
published in the Federal Register on
September 23, 1975, (40 FR 43745), all
applicants for registration to import a
basic class of any controlled substances
in schedule I or II are, and will continue
to be, required to demonstrate to the
Deputy Assistant Administrator, Office
of Diversion Control, Drug Enforcement
Administration, that the requirements
for such registration pursuant to 21
U.S.C. 958(a); 21 U.S.C. 823(a); and 21
CFR 1301.34(b), (c), (d), (e), and (f) are
satisfied.
VerDate Mar<15>2010
18:09 Oct 25, 2010
Jkt 223001
[FR Doc. 2010–27023 Filed 10–25–10; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Pursuant to Title 21 Code of Federal
Regulations 1301.34(a), this is notice
that on July 12, 2010, Noramco, Inc.,
Division of Ortho-McNeil, Inc., 500
Swedes Landing Road, Wilmington,
Delaware 19801, made application by
renewal to the Drug Enforcement
Administration (DEA) for registration as
an importer of the basic classes of
controlled substances listed in schedule
II:
Drug
Schedule
Raw Opium (9600) .......................
Concentrate of Poppy Straw
(9670).
Tapentadol (9780) ........................
II
II
II
Any such comments or objections
should be addressed, in quintuplicate,
to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), 8701 Morrissette Drive,
Springfield, Virginia 22152; and must be
filed no later than November 26, 2010.
This procedure is to be conducted
simultaneously with, and independent
of, the procedures described in 21 CFR
1301.34(b), (c), (d), (e), and (f). As noted
in a previous notice published in the
Federal Register on September 23, 1975,
(40 FR 43745–46), all applicants for
registration to import a basic class of
any controlled substances in schedule I
or II are, and will continue to be,
required to demonstrate to the Deputy
Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration, that the requirements
for such registration pursuant to
21U.S.C. 958(a); 21 U.S.C. 823(a); and
21 CFR 1301.34(b), (c), (d), (e), and (f)
are satisfied.
Dated: October 19, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator,Office of
Diversion Control,Drug Enforcement
Administration.
[FR Doc. 2010–27025 Filed 10–25–10; 8:45 am]
BILLING CODE 4410–09–P
The company plans to import the Raw
Opium (9600) and Concentrate of Poppy
Straw (9670) to manufacture other
controlled substances. The company
plans to import Tapentadol (9780) in
intermediate form for the bulk
manufacture of Tapentadol (9780)
which it will distribute to its customers.
No comments, objections, or requests
for any hearings will be accepted on any
application for registration or reregistration to import crude opium,
poppy straw, concentrate of poppy
straw, and coca leaves. As explained in
the Correction to Notice of Application
pertaining to Rhodes Technologies, 72
FR 3417 (2007), comments and requests
for hearings on applications to import
narcotic raw material are not
appropriate.
Any bulk manufacturer who is
presently, or is applying to be,
registered with DEA to manufacture
such basic classes of controlled
substances listed in schedule I or II,
which fall under the authority of section
1002(a)(2)(B) of the Act [21 U.S.C.
952(a)(2)(B)] may, in the circumstances
set forth in 21 U.S.C. 958(i), file
comments or objections to the issuance
of the proposed registration and may, at
the same time, file a written request for
a hearing on such application pursuant
to 21 CFR 1301.43 and in such form as
prescribed by 21 CFR 1316.47.
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Application
Pursuant to § 1301.33(a) of Title 21 of
the Code of Federal Regulations (CFR),
this is notice that on July 12 2010,
Aldrich Chemical Company Inc., DBA
Isotec, 3858 Benner Road, Miamisburg,
Ohio 45342–4304, made application by
renewal to the Drug Enforcement
Administration (DEA) as a bulk
manufacturer of the basic classes of
controlled substances listed in
schedules I and II:
Drug
Gamma
Hydroxybutyric
Acid
(2010).
Methaqualone (2565) ...................
Ibogaine (7260) ............................
Tetrahydrocannabinols (7370) .....
2,5–Dimethoxyamphetamine
(7396).
Psilocyn (7438) .............................
Normorphine (9313) .....................
Acetylmethadol (9601) .................
Alphacetylmethadol except levo–
alphacetylmethadol (9603).
Normethadone (9635) ..................
Norpipanone (9636) .....................
3–Methylfentanyl (9813) ...............
E:\FR\FM\26OCN1.SGM
26OCN1
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
]]>Agencies
[Federal Register Volume 75, Number 206 (Tuesday, October 26, 2010)]
[Notices]
[Page 65658]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-27023]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;Notice of Application
This is notice that on July 22, 2010, Cody Laboratories Inc., 601
Yellowstone Avenue, Cody, Wyoming 82414-9321, made application by
renewal to the Drug Enforcement Administration (DEA) for registration
as an importer of the basic classes of controlled substances listed in
schedule II:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Raw Opium (9600)........................... II
Concentrate of Poppy Straw (9670).......... II
------------------------------------------------------------------------
The company plans to import narcotic raw materials for
manufacturing and further distribution to its customers. The company is
registered with DEA as a manufacturer of several controlled substances
that are manufactured from raw opium, poppy straw, and concentrate of
poppy straw.
As explained in the Correction to Notice of Application pertaining
to Rhodes Technologies, 72 FR 3417 (2007), comments and requests for
hearings on applications to import narcotic raw material are not
appropriate.
As noted in a previous notice published in the Federal Register on
September 23, 1975, (40 FR 43745), all applicants for registration to
import a basic class of any controlled substances in schedule I or II
are, and will continue to be, required to demonstrate to the Deputy
Assistant Administrator, Office of Diversion Control, Drug Enforcement
Administration, that the requirements for such registration pursuant to
21 U.S.C. 958(a); 21 U.S.C. 823(a); and 21 CFR 1301.34(b), (c), (d),
(e), and (f) are satisfied.
Dated: October 19, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator,Office of Diversion Control,Drug
Enforcement Administration.
[FR Doc. 2010-27023 Filed 10-25-10; 8:45 am]
BILLING CODE 4410-09-P
